No photo of Robert Zielinski

View Scopus Profile

Robert Zielinski

 https://orcid.org/0000-0002-4807-8523
Calculated based on number of publications stored in Pure and citations from Scopus
20122026

Research activity per year

Personal profile

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being
  • SDG 9 - Industry, Innovation, and Infrastructure
  • SDG 16 - Peace, Justice and Strong Institutions

Qualifications

Bachelor of Medicine and Surgery, University of Sydney

Fingerprint

Dive into the research topics where Robert Zielinski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further

  • Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial

    Carlino, M. S., Gao, B., Michael, M., Marshall, H., Gunjur, A., Chan, H., Zielinski, R., So, J., Harris, S. J., Kee, D., Collins, I. M., Lam, W. S., Lyle, M., Underhill, C., Brown, M. P., Harrup, R., Wong, S. F., Grady, J., Ballinger, M. & Tavancheh, E. & 5 others, Thomas, D. M., Palmer, J., Wilkie, K., Cebon, J. & Klein, O., 2026, (E-pub ahead of print (In Press)) In: JAMA Oncology.

    Research output: Contribution to journal › Article › peer-review

    1 Citation (Scopus)

  • Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial

    Chia, J. W. K., Segelov, E., Deng, Y., Ho, G. F., Wang, W., Han, S., Sharma, A., Ding, K., Chen, G., Jeffery, M. G., Tham, C. K., Ahn, J. B., Nott, L., Zielinski, R., Chao, T. Y., van Hagen, T., Wei, P. L., Day, F., Mehta, S. & Yau, T. & 10 others, Peng, J., Hayes, T. M., Li, Y., Gandhi, M., Foo, E. M. J., Rahman, N., Rothwell, P., Ali, R., Simes, J. & Toh, H. C., Mar 2025, In: The Lancet Gastroenterology and Hepatology. 10, 3, p. 198-209 12 p.

    Research output: Contribution to journal › Article › peer-review

    8 Citations (Scopus)

  • Best of both worlds? linking comprehensive and noncomprehensive cancer centers

    Underhill, C., Sabesan, S. & Zielinski, R., Jun 2025, In: Cancers. 131, 12, 2 p., e35907.

    Research output: Contribution to journal › Article › peer-review

  • Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial

    De Santis, M., Palou Redorta, J., Nishiyama, H., Krawczyński, M., Seyitkuliev, A., Novikov, A., Guerrero-Ramos, F., Zukov, R., Kato, M., Kawahara, T., Goeman, L., Puente, J., Hellmis, E., Powles, T., Radziszewski, P., Gust, K. M., Vasey, P., Bigot, P., Fradet, Y. & Hunting, J. & 154 others, Armstrong, J., Boulos, S., Hois, S., Shore, N. D., Anderson, P., Brungs, D., Davis, I., Glasgow, A., Harris, C., Parente, P., Patel, M., Vasey, P., Vela, I., Zielinski, R., Buchegger, J., Gust, K., Horninger, W., Hutterer, G., Loidl, W., Luger, F., Lusuardi, L., Pichler, R., Ameye, F., Goeman, L., Joniau, S., Roumeguère, T., Fradet, Y., Izard, J., Kulkarni, G., Paradis, J. B., Saad, F., Rahmene Azzouzi, A., Barthelemy, P., Bigot, P., Colombel, M., Deturmeny, J., Lebret, T., Robert, G., Saint, F., Topart, D., Bögemann, M., Casuscelli, J., De Santis, M., Feyerabend, S., Garcia-Schürmann, M., Hatiboglu, G., Hegele, A., Hellmis, E., Keil, C., Klier, J., Pulte, T., Pursche, L., Schmitz-Dräger, B., Schütz, V., Spiegelhalder, P., Stagge, E., Tosev, G., von Klot, C., Arai, G., Bekku, K., Etani, T., Hashine, K., Inokuchi, J., Izumi, K., Izumi, K., Kamoto, T., Kandori, S., Kato, M., Kawahara, T., Kawai, N., Kikuchi, E., Kimura, T., Kitamura, H., Kobayashi, Y., Kondo, Y., Masumori, N., Matsuo, T., Miyata, Y., Mizuno, R., Mukai, S., Mutaguchi, J., Naiki, T., Nishimura, K., Ohyama, C., Okamoto, T., Saito, K., Sakai, H., Sugimoto, M., Takamoto, A., Tamada, S., Tanaka, N., Yonese, J., Yoshimura, K., De Reijke, T., Hunting, J., Oddens, J., Westgeest, H., Demkow, T., Korożan, M., Kozłowski, R., Krawczyński, M., Kwiatkowski, M., Masłowski, M., Radziszewski, P., Sadowska, U., Tupikowski, K., Zaucha, R., Zdrojowy, R., Atduev, V., Karyakin, O., Kislov, N., Kopyltsov, E., Komyakov, B., Novikov, A., Orlov, I., Semenov, A., Severtsev, A., Seyitkuliev, A., Smirnov, R., Topuzov, T., Vasiliev, A., Zukov, R., Álvarez-Maestro, M., Alcaraz, A., Almagro-Casado, E., Bonfill, T., Caballero Díaz, C., Cecchini Rosell, L., Delgado Mingorance, J. I., Gonzalez Cáliz, C., Guerrero-Ramos, F., Hannaoui Hadi, N., Herrera Imbroda, B., Hevia Suáre, M., Moyano Calvo, J. L., Pascual Piédrola, J. I., Puente, J., Raventos Busquets, C. X., Rico López, J., Rodríguez-Faba, Ó., Torres Roca, M., Vázquez Mazón, F. J., Virizuela Echaburu, J., Douglas, J., Enting, D., Jones, R., Linch, M., Mostafid, H., Noon, A., Patel, K., Patel, P., Powles, T., Sephton, M. & Varughese, M., 8 Nov 2025, In: The Lancet. 406, 10516, p. 2221-2234 14 p.

    Research output: Contribution to journal › Article › peer-review

    1 Citation (Scopus)

  • Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)

    ANZUP Cancer Trials Group, 1 Mar 2025, In: Future oncology (London, England). 21, 6, p. 627-636 10 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    1 Citation (Scopus)
View all 46 research outputs